Patrick Hsu

Patrick Hsu is a prominent figure in the field of bioengineering and genomics. He is the Co-Founder and Core Investigator of the Arc Institute, as well as an Assistant Professor of Bioengineering at the University of California, Berkeley.12 His research focuses on developing novel molecular tools to manipulate gene circuits at the DNA and RNA levels, with applications in neurodegenerative and immune-related disorders.2

Hsu's career includes significant roles such as:

1. Principal Investigator at the Salk Institute for Biological Studies (2015-2019)
2. Group Leader at Editas Medicine (2014-2015)
3. PhD Candidate in Feng Zhang's lab at the Broad Institute of MIT and Harvard (2010-2014)1

He has received numerous awards and honors, including:

• NIH Director's Early Independence Award ($1M) in 2015
• Forbes 30 Under 30 in 2015
• MIT Technology Review Innovators Under 35 in 2019
• Rainwater Prize for Innovative Early-Career Scientist in 2020
• Amgen Young Investigator Award in 20211

Hsu is also active in the investment and entrepreneurship space, working on projects that bridge biology and artificial intelligence.3 Recently, he co-led a $142M seed round for EvolutionaryScale, a company working on generative AI for CRISPR design.45